G. Morsica

发表

Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet

D. Montefiori, B. Ferko, A. Rossi, 2012, International journal of molecular sciences.

Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment.

A. Lazzarin, G. Sitia, C. Foppa, 2000, AIDS.

Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients

A. Lazzarin, P. Cinque, S. Racca, 2005, AIDS.

Evolution of hepatitis C virus non‐structural 5A gene in the progression of liver disease to hepatocellular carcinoma

M. Bernardi, M. S. De Mitri, R. Cassini, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma.

M. Zoli, A. Alberti, M. Bernardi, 2002, Journal of hepatology.

Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies

M. Bernardi, A. Alberti, G. Sitia, 2000, Journal of medical virology.

Replication of hepatitis C virus in B lymphocytes (CD19+)

L. Lopalco, A. Lazzarin, G. Sitia, 1999, Blood.

New infection with heterotypic hepatitis C virus in a patient with long-term hepatitis C virus eradication.

M. Zoli, M. Bernardi, M. S. De Mitri, 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV

L. Galli, A. Castagna, H. Hasson, 2022, PloS one.

HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy

A. Lazzarin, B. Foley, M. Ciccozzi, 2020, Infection.

Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients

L. Galli, A. Castagna, M. Ranzenigo, 2022, Journal of oncology.

Natural Killer‐Cell Cytotoxicity in HIV‐Positive and HIV‐Negative Patients with and Without Severe Course of Hepatitis B Virus Infection

A. Lazzarin, C. Paties, M. Malnati, 2005, Scandinavian journal of immunology.

A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV‐infected individuals with occult HBV infection

M. Bernardi, M. S. De Mitri, R. Cassini, 2013, Journal of viral hepatitis.

Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy.

A. Lazzarin, L. Galli, E. Boeri, 2003, Journal of acquired immune deficiency syndromes.

Virological patterns of hepatitis C virus in chronic hepatitis C with biochemical sustained response to interferon therapy

A. Lazzarin, T. Iervese, M. S. De Mitri, 1996, Hepatology.

Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort

M. Massari, F. Morisco, A. Federico, 2020, Hepatology International.

Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use

G. Morsica, S. Bagaglio, C. Uberti-Foppa, 2017, Drugs.

Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment

G. Morsica, M. Merli, S. Bagaglio, 2016, Viruses.

Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19

A. Lazzarin, A. Zangrillo, P. Cinque, 2020, Scientific Reports.

Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.

A. Lazzarin, L. Galli, M. Cernuschi, 2016, The new microbiologica.

Hepatitis B virus binds to peripheral blood mononuclear cells via the pre S1 protein.

A. Alberti, P. Pontisso, R. Zambello, 1991, Journal of hepatology.

Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy

A. Lazzarin, M. Ciccozzi, E. Sagnelli, 2020, Epidemiology and Infection.

Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.

A. Lazzarin, M. S. De Mitri, G. Morsica, 1997, Italian journal of gastroenterology and hepatology.

Real-Life use of Elbasvir/Grazoprevir in Adults and Elderly Patients: A Prospective Evaluation of Comedications used in the PITER Cohort

P. Di Stefano, A. Licata, G. Migliorino, 2020, Antiviral therapy.

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman.

A. Lazzarin, Liviana Della Torre, H. Hasson, 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Non‐invasive fibrosis biomarkers – APRI and Forns – are associated with liver stiffness in HIV‐monoinfected patients receiving antiretroviral drugs

A. Lazzarin, L. Galli, A. Castagna, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Detection of hepatitis C virus RNA by methods using phenol-chloroform or silica particles

A. Lazzarin, G. Morsica, R. Novati, 1995, Journal of clinical microbiology.

Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection

G. Bianchi, M. Bernardi, M. S. De Mitri, 2005, Archives of Virology.

Latent hepatitis B virus infection in childhood hepatocellular carcinoma analysis by polymerase chain reaction

A. Alberti, P. Pontisso, G. Basso, 1992, Cancer.

Acute self-limiting hepatitis C after possible sexual exposure: sequence analysis of the E-2 region of the infected patient and sexual partner.

A. Lazzarin, G. Sitia, G. Tambussi, 2001, Scandinavian journal of infectious diseases.

Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection.

A. Lazzarin, D. Roccatello, G. Piccoli, 1997, Clinical and experimental immunology.

Modelling the impact of protein-kinase R allelic variant on HIV biomarkers trajectories by means of latent class mixed models

C. Brombin, C. Di Serio, F. Cugnata, 2022, Scientific Reports.

Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin

F. Trentini, A. Lazzarin, C. Di Serio, 2015, Medicine.

Molecular characterization of occult and overt hepatitis B (HBV) infection in an HIV-infected person with reactivation of HBV after antiretroviral treatment interruption

A. Lazzarin, G. Morsica, S. Bagaglio, 2010, Infection.

Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients

M. Capobianchi, A. Monforte, P. Cicconi, 2009, Journal of acquired immune deficiency syndromes.

Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses

M. Bernardi, G. Bianchi, M. Bernardi, 2007, Archives of Virology.

Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV‐related hepatocellular carcinoma

M. Bernardi, M. Bernardi, M. S. De Mitri, 2006, Journal of viral hepatitis.

Mutations in the E2–PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma

A. Lazzarin, C. Paties, G. Bianchi, 2005, Journal of viral hepatitis.

Response to Haart and Gb Virus Type C Coinfection in a Cohort of Antiretroviral-Naive HIV-Infected Individuals

G. Ippolito, M. Capobianchi, A. Monforte, 2005, Antiviral Therapy.

Evolution of the E2 region of hepatitis C virus in an infant infected by mother‐to‐infant transmission

A. Lazzarin, G. Sitia, D. Cella, 2001, Journal of Medical Virology.

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV

A. Alberti, P. Pontisso, F. Noventa, 1992, The Lancet.

NS3 protease resistance-associated substitutions in liver tissue and plasma samples from patients infected by hepatitis C virus genotype 1A or 1B

A. Lazzarin, H. Hasson, G. Morsica, 2017, Archives of Virology.

A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study.

L. Galli, M. Locatelli, H. Hasson, 2019, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29‐year longitudinal study

A. Gatta, P. Cadrobbi, C. Crivellaro, 2006, Hepatology.

Occult hepatitis B virus infection in a Cohort of HIV-positive patients: Correlation with hepatitis C virus coinfection, virological and immunological features

A. d’Arminio Monforte, A. Lazzarin, D. Santoro, 2009, Infection.

OUTCOME OF ACUTE HEPATITIS B VIRUS INFECTION IN HIV-1 INFECTED PATIENTS: POSSIBLE FACTORS ASSOCIATED WITH RESOLUTION OR CHRONICITY

L. Galli, S. Bossolasco, A. Castagna, 2019, Journal of acquired immune deficiency syndromes.

Geographic Distribution of HCV-GT3 Subtypes and Naturally Occurring Resistance Associated Substitutions

A. Galli, H. Hasson, G. Morsica, 2019, Viruses.

The appropriate method of evaluating the dynamics of hepatitis B virus in patients receiving antiviral treatment: the other side of the coin.

G. Morsica, S. Bagaglio, Chiara Lodrini, 2005, AIDS (London).

Serum HBV-DNA in anti-HBe positive patients detected by filter and liquid phase hybridization assays.

G. Fattovich, L. Brollo, A. Alberti, 1989, Molecular and cellular probes.

Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption

A. Lazzarin, G. Bianchi, A. Castagna, 2011, Infection.

Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C

F. Baldanti, F. Ceccherini‐Silberstein, V. Vullo, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study

C. Di Serio, A. Castagna, A. Galli, 2017, PloS one.

Polymerase-chain-reaction-based semi-quantification of hepatitis D viraemia in patients treated with high doses of α2b interferon

G. Fattovich, A. Alberti, G. Giustina, 1994 .

Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report

L. Albarello, P. Biswas, C. Fortis, 2009, Journal of medical case reports.

Natural polymorphisms in the resistance associated sites of HCV-G1 NS5B domain and correlation with geographic origin of HCV isolates

A. Olgiati, H. Hasson, G. Morsica, 2018, Virology Journal.

Detection of hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in HIV/HCV-coinfected individuals treated with antiretroviral therapy.

A. Lazzarin, L. Galli, G. Morsica, 2009, Journal of acquired immune deficiency syndromes.

Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort.

M. Massari, M. Brunetto, M. Galli, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

A. Lazzarin, A. Zangrillo, P. Cinque, 2020, Clinical Microbiology and Infection.

Are artemisinin-based combination therapies effective against Plasmodium malariae ?

A. Lazzarin, H. Hasson, G. Morsica, 2013 .

Beyond stigma: Monkeypox infection in a 27‐year‐old woman

A. Castagna, S. Nozza, D. Canetti, 2022, Journal of medical virology.

Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.

A. Lazzarin, M. Clementi, M. S. De Mitri, 2003, Journal of biological regulators and homeostatic agents.

Dynamic change in the NS3 protease domain in HIV/HCV-coinfected patients naïve to anti-HCV protease inhibitors.

A. Lazzarin, H. Hasson, G. Morsica, 2017, The new microbiologica.

Distribution of natural resistance to NS3 protease inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in genotype 1b of HIV-infected patients.

A. Lazzarin, A. Galli, H. Hasson, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.

R. Bruno, A. Lazzarin, L. Galli, 2003, Journal of biological regulators and homeostatic agents.

Mother-to-child transmission of TT virus: sequence analysis of non-coding region of TT virus in infected mother-infant pairs

A. Lazzarin, G. Sitia, D. Prati, 2002, Archives of Virology.

Compartmentalization of Resistance-Associated Substitutions in HIV/HCV-Infected Patients: Possible Correlation with Infecting HCV Genotype

H. Hasson, G. Morsica, S. Bagaglio, 2021, Viruses.

Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection.

B. Autran, P. Debré, F. Macciardi, 2012, The Journal of infectious diseases.

Hepatitis C virus infection in blood donors with indeterminate results in second‐generation recombinant immunoblot assay

A. Lazzarin, G. Morsica, S. Panese, 1994, Transfusion.

Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus.

A. Lazzarin, H. Hasson, G. Morsica, 2013, The Journal of antimicrobial chemotherapy.

Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions

A. d’Arminio Monforte, A. Lazzarin, A. Castagna, 1994, AIDS.

Naive HIV/HCV-Coinfected Patients Have Higher Intrahepatic Pro-Inflammatory Cytokines than Coinfected Patients Treated with Antiretroviral Therapy

A. Lazzarin, C. Paties, G. Sitia, 2005, Antiviral therapy.

Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection

A. Lazzarin, D. Roccatello, G. Piccoli, 1997 .

Evolution of the E2 region of hepatitis C virus in an infant infected by mother-to-infant transmission.

A. Lazzarin, G. Sitia, D. Cella, 2001, Journal of medical virology.

Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy

L. Galli, A. Castagna, H. Hasson, 2023, Cancers.

Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort.

M. Massari, P. Lampertico, G. Raimondo, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical and Virologic Characteristics of HIV-1 Positive Patients with Delta Hepatitis

H. Hasson, G. Morsica, S. Bagaglio, 2018 .

GB Virus C and Hepatitis C Virus Infection in Patients with Mixed Cryoglobulinemia

D. Roccatello, G. Sitia, G. Morsica, 2000, Annals of Internal Medicine.

Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV‐infected patients

A. Lazzarin, C. Foppa, A. Castagna, 1997, Journal of medical virology.

Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression.

A. Lazzarin, E. Santagostino, E. Vicenzi, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a.

R. Bruno, A. Lazzarin, M. S. De Mitri, 2004, AIDS (London).

A Prospective Italian Study on Baseline NS3 and NS5A Resistance to Direct-Acting Antivirals in a Real-World Setting of HIV-1/HCV Coinfected Patients and Association with Treatment Outcome

C. Foppa, A. Galli, H. Hasson, 2020, Viruses.

Natural polymorphisms in the resistance associated sites of HCV-G1 NS5B domain and correlation with geographic origin of HCV isolates

A. Olgiati, H. Hasson, G. Morsica, 2018, Virology Journal.

Does hepatitis B virus play a role in primary liver cancer in children of Western countries?

A. Alberti, P. Pontisso, G. Basso, 1991, Cancer detection and prevention.

P0909 : Analysis of natural resistance profile to NS5A replication complex inhibitors in different Hepatitis C genotypes

A. Lazzarin, H. Hasson, G. Morsica, 2015 .

Non‐invasive fibrosis biomarkers – APRI and Forns – are associated with liver stiffness in HIV‐monoinfected patients receiving antiretroviral drugs

A. Lazzarin, L. Galli, A. Castagna, 2013, Liver international : official journal of the International Association for the Study of the Liver.